Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neural Architecture of Emotion Regulation, Adolescent Development and Depression
Cellular and Molecular Basis of Hippocampal Atrophy in Depressed Female Monkeys
Development of Portable Computer Programs for Human Genetic Analysis
Trans-Acting Factors Regulating Adh Gene Expression
Efficacy of Support Groups for Mexican American
Recently added grants:
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
APOBEC proteins as drivers of chromosomal translocations in solid cancers
Tri-City Cervical Cancer Prevention Study among Women in the Justice System
Gene Delivery Nanoparticles to Treat Glioblastoma
Development of IDO PET agents for immunotherapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025140-002
Application #
6828866
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant